Nix key facts
as of Oct 2026- Developer of a wearable biosensor designed to detect hydration levels in athletes, soldiers, and laborers.
- Nix is valued at approximately $76.0M as of Oct 2026 (last reported valuation).
- It has raised $16.0M; the latest was Later Stage VC in Sep 2025.
- Notable investors include Techstars, MassChallenge, Harvard Innovation Launch Lab, Great Oaks Venture Capital, The MBA Fund — 15 tracked in total.
- Status: Privately Held (backing).
Nix's last reported valuation, Dec 2022. Nothing priced has surfaced since.
- ·The complete investor list: 15 names
- ·Watch Nix: the Monday email on marks, rounds and moves
Nix funding rounds
No funding rounds for Nix are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Nix
15+Nix valuation
Nix's last reported valuation was $76 million in Dec 2022. No priced round, secondary trade or fund mark has surfaced since.
Nix investors
15 investors are on record for Nix, including Techstars, MassChallenge, Harvard Innovation Launch Lab and Great Oaks Venture Capital.
About Nix
Developer of a wearable biosensor designed to detect hydration levels in athletes, soldiers, and laborers. The company's sensors provide real-time, personal hydration status for athletes, who are currently guessing at their fluid needs during training and competition, enabling athletes to remove the guesswork of when to drink, what to drink, and how much to drink.
- Sector
- Healthcare
- HQ
- Norwell, MA, United States
- Founded
- 2015
- Employees
- 34
- Website
- nixbiosensors.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.